Information  X 
Enter a valid email address

Mobeus Inc&Gwth 4 (MIG4)

  Print          Annual reports

Thursday 16 April, 2020

Mobeus Inc&Gwth 4

Dividend Investment Scheme - Recommencement

RNS Number : 9492J
Mobeus Income & Growth 4 VCT PLC
16 April 2020
 

Mobeus Income & Growth 4 VCT plc

Dividend Investment Scheme ("Scheme") - recommencement and changes to the terms and conditions ("Scheme Rules")

The Board is pleased to announce that it has decided to recommence the Scheme, effective from 2 June 2020.

As part of the Board's consideration to recommence the Scheme, it has carried out a review of the Scheme Rules and it has decided to make certain amendments.

The key change is to amend the price at which new shares will be issued under the Scheme to the latest net asset value per existing share, as is the current market practice, rather than, as previously, at the higher of 70% of the net asset value per share or the mid-market price per share (which, in practice, resulted in shares being issued at an effective discount to net asset value per share of around 10%). The other changes are more updates in nature.

Participants in the Scheme will shortly be given notice of the proposed changes to the Scheme, which will take effect on 2 June 2020 (this being the date of recommencement), and will apply to all dividends paid by the Company after that date. Current participants who wish to continue participating in the Scheme do not need to take any action.

New participants joining the Scheme from the date of this announcement will do so under the new Scheme Rules.

For further details and to access the Scheme Rules, please visit www.mig4vct.co.uk and refer to the Dividends section heading.

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary

020 7024 7600

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DIVIFMFTMTJBBAM

a d v e r t i s e m e n t